|
PHF2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.416360E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.493980E-01 |
| Normal-vs-Stage2 |
3.369800E-02 |
| Normal-vs-Stage3 |
4.2552000000029E-05 |
| Normal-vs-Stage4 |
2.13230000001285E-06 |
| Stage1-vs-Stage2 |
1.499230E-01 |
| Stage1-vs-Stage3 |
4.433800E-04 |
| Stage1-vs-Stage4 |
4.14589999999659E-05 |
| Stage2-vs-Stage3 |
4.470800E-01 |
| Stage2-vs-Stage4 |
1.806600E-01 |
| Stage3-vs-Stage4 |
3.616600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.261000E-03 |
| Normal-vs-AfricanAmerican |
5.883400E-01 |
| Normal-vs-Asian |
5.514000E-01 |
| Caucasian-vs-AfricanAmerican |
1.176410E-01 |
| Caucasian-vs-Asian |
4.675900E-02 |
| AfricanAmerican-vs-Asian |
4.100200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.020200E-04 |
| Normal-vs-Female |
1.137580E-01 |
| Male-vs-Female |
1.618180E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.525820E-01 |
| Normal-vs-Age(41-60Yrs) |
6.815600E-02 |
| Normal-vs-Age(61-80Yrs) |
3.440300E-04 |
| Normal-vs-Age(81-100Yrs) |
8.447100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.555400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.002800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.346170E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.077730E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.529900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.358400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.901850E-02 |
| Normal-vs-Grade 2 |
3.003000E-01 |
| Normal-vs-Grade 3 |
2.08729999995327E-06 |
| Normal-vs-Grade 4 |
1.87789999994692E-06 |
| Grade 1-vs-Grade 2 |
1.583520E-02 |
| Grade 1-vs-Grade 3 |
1.39269999999136E-06 |
| Grade 1-vs-Grade 4 |
2.39950000002764E-06 |
| Grade 2-vs-Grade 3 |
3.35100000004029E-06 |
| Grade 2-vs-Grade 4 |
4.10520000000414E-05 |
| Grade 3-vs-Grade 4 |
2.052600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.263600E-01 |
| Normal-vs-ccB subtype |
4.2838000000045E-05 |
| ccA subtype-vs-ccB subtype |
6.08249999999311E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.697320E-03 |
| Normal-vs-N1 |
1.524340E-03 |
| N0-vs-N1 |
1.768790E-01 |
|
|
